Alx Oncology Holdings Inc
ALXOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Alx Oncology Holdings Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Alx Oncology Holdings Inc — 10-K filed Mar 9, 2023
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 17, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| NINE MASTS CAPITAL Ltd | 2026-03-31 | 20,623 | $41.3K | SEC filing |
| Almitas Capital LLC | 2026-03-31 | 3,173,834 | $6.36M | SEC filing |
| CITIGROUP INC | 2026-03-31 | 17 | $34 | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 466 | $934 | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 1,101,025 | Not shown | SEC filing |
| OMERS ADMINISTRATION Corp | 2026-03-31 | 75,000 | $150K | SEC filing |
| TCG Crossover Management, LLC | 2026-03-31 | 13,011,849 | $26.1M | SEC filing |
| Squadron Capital Management LLC | 2026-03-31 | 1,460,000 | $2.93M | SEC filing |
| venBio Partners LLC | 2026-03-31 | 12,884,638 | $25.8M | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 1,587,833 | $3.18M | SEC filing |
| TWO SIGMA SECURITIES, LLC | 2026-03-31 | 10,993 | $22K | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 10,515 | $21.1K | SEC filing |
| Invesco Ltd. | 2026-03-31 | 10,980 | $22K | SEC filing |
| Abel Hall, LLC | 2026-03-31 | 12,598 | $25.3K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 10,105 | $20.5K | SEC filing |
| 5AM Venture Management, LLC | 2026-03-31 | 3,057,325 | $6.13M | SEC filing |
| IEQ CAPITAL, LLC | 2026-03-31 | 92,233 | $185K | SEC filing |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 2026-03-31 | 37,997 | $74.9K | SEC filing |
| JSF Financial, LLC | 2026-03-31 | 17,500 | $35.1K | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 107,647 | $216K | SEC filing |
- Each value is checked against Alx Oncology Holdings Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Alx Oncology Holdings Inc's share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Lido Advisors, LLC: 13,220 shares reported 2025-12-31; 13,220 shares reported 2026-03-31.
- NORTHERN TRUST CORP: 149,097 shares reported 2025-12-31; 136,964 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 3,204,619 shares reported 2025-12-31; 1,988,559 shares reported 2026-03-31.
- CWM, LLC: 96 shares reported 2025-12-31; 65 shares reported 2026-03-31.
- STATE STREET CORP: 124,228 shares reported 2025-12-31; 175,828 shares reported 2026-03-31.
- BRIDGEWAY CAPITAL MANAGEMENT, LLC: 76,072 shares reported 2025-12-31; 76,072 shares reported 2026-03-31.
- NISA INVESTMENT ADVISORS, LLC: 1,106 shares reported 2025-12-31; 1,106 shares reported 2026-03-31.
- BANK OF AMERICA CORP /DE/: 531,845 shares reported 2025-12-31; 577,783 shares reported 2026-03-31.
- BANK OF NOVA SCOTIA: 105,858 shares reported 2025-12-31; 105,858 shares reported 2026-03-31.
- JANE STREET GROUP, LLC: 185,961 shares reported 2025-12-31; 95,101 shares reported 2026-03-31.
- MARSHALL WACE, LLP: 26,376 shares reported 2025-12-31; 3,757,216 shares reported 2026-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 423,099 shares reported 2025-12-31; 732,599 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
37 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Alx Oncology Holdings Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-07-11 · Pons Jaume: Larger than 108 of the 117 other insider sales of Common Stock on file. SEC filing
- 2024-06-04 · Pons Jaume: Larger than 108 of the 117 other insider sales of Common Stock on file. SEC filing
- 2024-05-06 · Pons Jaume: Larger than 108 of the 117 other insider sales of Common Stock on file. SEC filing
- 2024-04-16 · Pons Jaume: Larger than 116 of the 117 other insider sales of Common Stock on file. SEC filing
- 2024-04-04 · Pons Jaume: Larger than 108 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-13 · unknown owner: Larger than all 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-13 · George Jean: Larger than 106 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-13 · unknown owner: Larger than 106 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-09 · George Jean: Larger than 114 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-09 · Lettmann Jason: Larger than 114 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-08 · Lettmann Jason: Larger than 112 of the 117 other insider sales of Common Stock on file. SEC filing
- 2021-12-08 · George Jean: Larger than 112 of the 117 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-19 | Pinto Shelly · SVP, FINANCE AND CAO | Common Stock | S — Open market or private sale | −903 | 2.17 | SEC filing |
| 2026-03-19 | Lettmann Jason · CHIEF EXECUTIVE OFFICER | Common Stock | S — Open market or private sale | −12,311 | 2.17 | SEC filing |
| 2026-02-18 | Pinto Shelly · SVP, FINANCE AND CAO | Common Stock | S — Open market or private sale | −565 | 2.27 | SEC filing |
| 2026-02-02 | GOODMAN COREY S · Director, 10% owner | Common Stock | P — Open market or private purchase | +3,184,713 | 1.57 | SEC filing |
| 2026-01-06 | Pinto Shelly · SVP, FINANCE AND CAO | Common Stock | S — Open market or private sale | −3,925 | 1.11 | SEC filing |
| 2025-09-17 | Lettmann Jason · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +71,163 | 1.08 | SEC filing |
| 2025-09-16 | Lettmann Jason · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +21,070 | 1.07 | SEC filing |
| 2025-08-18 | Shantharam Harish · Chief Financial Officer | Common Stock | P — Open market or private purchase | +75,000 | 0.78 | SEC filing |
Showing 8 of 17 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-16 | Klencke Barbara · Chief Medical Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-04-16 | Knight Jeff E. · Chief Dev & Operating Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | +800,000 | SEC filing |
| 2026-03-03 | Klencke Barbara · Chief Medical Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | +700,000 | SEC filing |
| 2026-02-17 | Lettmann Jason · CHIEF EXECUTIVE OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,201 | SEC filing |
| 2026-01-26 | Shantharam Harish · Chief Financial Officer | Stock option (right to buy) | A — Grant, award, or other acquisition | +303,000 | SEC filing |
| 2026-01-26 | Pinto Shelly · SVP, FINANCE AND CAO | Stock option (right to buy) | A — Grant, award, or other acquisition | +192,000 | SEC filing |
| 2026-01-26 | Lettmann Jason · CHIEF EXECUTIVE OFFICER | Stock option (right to buy) | A — Grant, award, or other acquisition | +912,000 | SEC filing |
| 2026-01-20 | GOODMAN COREY S · Director, 10% owner | Stock Option (right to buy) | A — Grant, award, or other acquisition | +40,400 | SEC filing |
Showing 8 of 24 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.